Abstract
Purpose. The aim of this study was to characterize L-lactic acid transport using a conditionally immortalized rat retinal capillary endothelial cell line (TR-iBRB2) as a model of in vitro inner blood-retinal barrier (iBRB) to obtain a better understanding of the transport mechanism at the iBRB.
Methods. TR-iBRB2 cells were cultured at 33°C, and L-lactic acid uptake was monitored by measuring [14C]L-lactic acid at 37°C. The expression and mRNA level of monocarboxylate transporter (MCT)1 and MCT2 were determined by reverse transcription polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR with specific primers, respectively.
Results. The [14C]L-lactic acid uptake by TR-iBRB2 cells increased up to a pH of 5.0 and was inhibited in the presence of 10 mM L-lactic acid. The [14C]L-lactic acid uptake at pH 6.0 was both temperature- and concentration-dependent with a Michaelis-Menten constant of 1.7 mM and a maximum uptake rate of 15 nmol/(30 s · mg of protein). This process was reduced by carbonylcyanide p-trifluoromethoxy- phenylhydrazone (protonophore), α-cyano-4-hydroxycinnamate, and p-chloromercuribenzenesulfonate (typical inhibitors for H+-coupled monocarboxylic acid transport), suggesting that L-lactic acid uptake by TR-iBRB2 cells is a carrier-mediated transport process coupled with an H+ gradient. [14C]L-Lactic acid uptake was markedly inhibited by monocarboxylic acids but not dicarboxylic acids and amino acids. Moreover, salicylic and valproic acids competitively inhibited this process with an inhibition constant of 4.7 mM and 5.4 mM, respectively. Although MCT1 and MCT2 mRNA were found to be expressed in TR-iBRB2 cells, MCT1 mRNA was found to be present at a concentration 33-fold greater than that of MCT2 mRNA using quantitative real-time PCR. [14C]L-Lactic acid was significantly reduced by 5-(N,N-hexamethylene)-amiloride at pH 7.4 and Na+/H+ exchanger 1 mRNA was expressed in TR-iBRB2 cells.
Conclusion. L-Lactic acid transport at the iBRB is an H+-coupled and carrier-mediated mechanism via MCT1 that is competitively inhibited by monocarboxylate drugs.
Similar content being viewed by others
REFERENCES
J. A. Bonanno. Lactate-proton cotransport in rabbit corneal epithelium. Curr. Eye Res. 9:707-712. (1990).
C. Giasson and J. A. Bonanno. Facilitated transport of lactate by rabbit corneal endothelium. Exp. Eye Res. 59:73-81 (1994).
Y. Horibe, K. Hosoya, K. Kim, and V. H. L. Lee. Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva. Invest. Ophthalmol. Vis. Sci. 39:1436-1443 (1998).
N. J. Philp, H. Yoon, and E. F. Grollman. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am. J. Physiol. 274:R1824-R1828 (1998).
V. H. L. Lee and K. Hosoya. Drug delivery to the posterior segment. In S. J. Ryan (ed.), Retina Third Edition, Mosby, St. Louis, Missouri, 2001, pp. 2270-2285.
I. Tamai, H. Takanaga, H. Maeda, T. Ogthara, M. Yoneda, Y. Suzuki, and A. Tsuji. Proton-cotransport of pravastatin across intestinal brush-border membrane. Pharm. Res. 12:1727-1732 (1995).
A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res. 11:30-37 (1994).
C. N. Graymore. Biochemistry of retina. In C. N. Graymore (ed.), Biochemistry of the Eye, Academic Press, New York, 1970, pp. 645-735.
C. L. Poitry-Yamate, S. Poitry, and M. Tsacopoulos. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J. Neurosci. 15:5179-5191 (1995).
A. Alm and P. Törnquist. Lactate transport through the blood-retinal and the blood-brain barrier in rats. Ophthalmic Res. 17:181-184 (1985).
P. A. Stewart and U. I. Tuor. Blood-eye barriers in the rat: correlation of ultrastructure with function. J. Comp. Neurol. 340:566-576 (1994).
D. Z. Gerhart, R. L. Leino, and L. R. Drewes. Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina. Neuroscience 92:367-375 (1999).
K. Hosoya, M. Tomi, S. Ohtsuki, H. Takanaga, M. Ueda, N. Yanai, M. Obinata, and T. Terasaki. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp. Eye Res. 72:163-172 (2001).
T. Terasaki and K. Hosoya. Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol. Pharm. Bull. 24:111-118 (2001).
K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:879-885 (1981).
Y. Kido, I. Tamai, M. Okamoto, F. Suzuki, and A. Tsuji. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm. Res. 17:55-62 (2000).
H. Takanaga, I. Tamai, S. Inaba, Y. Sai, H. Higashida, H. Yamamoto, and A. Tsuji. cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter. Biochem. Biophys. Res. Commun. 217:370-377 (1995).
J. Orlowski, R. A. Kandasamy, and G. E. Shull. Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins. J. Biol. Chem. 267:9331-9339 (1992).
W. M. Pardridge. Brain Metabolism A perspective from the blood-brain barrier. Physiol. Rev. 63:1481-1535 (1983).
S. E. Buchalter, M. R. Crain, and R. Kreisberg. Regulation of lactate metabolism in vivo. Diabetes Metab. Rev. 5:379-391 (1989).
B. B. Brodie and C. A. M. Hogben. Some physico-chemical factors in drug action. J. Pharm. Pharmacol. 9:345-380 (1957).
I. Tamai and A. Tsuji. Drug delivery through the blood-brain barrier. Adv. Drug Deliv. Rev. 19:401-424 (1996).
C. K. Garcia, M. S. Brown, R. K. Pathak, and J. L. Goldstein. cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J. Biol. Chem. 270:1843-1849 (1995).
M. Delvaux, M. J. Bastie, J. Chentoufi, E. J. Cragoe, N. Vaysse, and A. Ribet. Amiloride and analogues inhibit Na+-H+ exchange and cell proliferation in AR42J pancreatic cell line. Am. J. Physiol. 259:G842-G849 (1990).
I. Tamai, H. Takanaga, H. Maeda, Y. Sai, T. Ogihara, H. Higashida, and A. Tsuji. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem. Biophys. Res. Commun. 214:482-489 (1995).
A. J. Adler and R. E. Southwick. Distribution of glucose and lactate in the interphotoreceptor matrix. Ophthalmic Res. 24:243-252 (1992).
E. Kenyon, A. Maminishkis, D. P. Joseph, and S. S. Miller. Apical and basolateral membrane mechanisms that regulate pHi in bovine retinal pigment epithelium. Am. J. Physiol. 273:C456-C472 (1997).
L. R. Drewes. Transport of the brain fuels, glucose and lactate. In O. B. Paulson, G. M. Knudsen, and T. Moos (eds.), Brain Barrier Systems, Munksgaard, Copenhagen, 1999, pp. 285-300.
G. M. Knudsen, O. B. Paulson, and M. M. Hertz. Kinetic analysis of the human blood-brain barrier transport of lactate and its influence by hypercapnia. J. Cerebral. Blood Flow Metab. 11:581-586 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hosoya, Ki., Kondo, T., Tomi, M. et al. MCT1-Mediated Transport of L-Lactic Acid at the Inner Blood–Retinal Barrier: A Possible Route for Delivery of Monocarboxylic Acid Drugs to the Retina. Pharm Res 18, 1669–1676 (2001). https://doi.org/10.1023/A:1013310210710
Issue Date:
DOI: https://doi.org/10.1023/A:1013310210710